A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 16,408 shares of CORT stock, worth $946,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,408
Previous 16,408 -0.0%
Holding current value
$946,413
Previous $759,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$29.51 - $46.26 $2,478 - $3,885
-84 Reduced 0.51%
16,408 $759,000
Q2 2024

Jul 29, 2024

SELL
$22.21 - $34.48 $95,458 - $148,195
-4,298 Reduced 20.67%
16,492 $535,000
Q1 2024

Apr 25, 2024

BUY
$21.1 - $27.46 $717 - $933
34 Added 0.16%
20,790 $523,000
Q4 2023

Jan 30, 2024

BUY
$24.82 - $32.88 $174,683 - $231,409
7,038 Added 51.3%
20,756 $674,000
Q1 2023

May 08, 2023

BUY
$19.2 - $24.47 $43,449 - $55,375
2,263 Added 19.76%
13,718 $297,000
Q4 2022

Feb 01, 2023

SELL
$19.95 - $29.96 $30,363 - $45,599
-1,522 Reduced 11.73%
11,455 $232,000
Q2 2022

Aug 09, 2022

SELL
$17.33 - $25.3 $42,267 - $61,706
-2,439 Reduced 15.82%
12,977 $309,000
Q4 2021

Feb 01, 2022

BUY
$17.1 - $23.34 $52,702 - $71,933
3,082 Added 24.99%
15,416 $305,000
Q1 2021

May 03, 2021

SELL
$23.49 - $30.56 $76,295 - $99,258
-3,248 Reduced 20.84%
12,334 $293,000
Q2 2020

Jul 28, 2020

BUY
$11.0 - $18.26 $84,898 - $140,930
7,718 Added 98.14%
15,582 $262,000
Q1 2020

May 06, 2020

BUY
$10.11 - $14.04 $18,693 - $25,959
1,849 Added 30.74%
7,864 $94,000
Q1 2019

Apr 29, 2019

BUY
$10.03 - $15.71 $1,534 - $2,403
153 Added 2.61%
6,015 $71,000
Q3 2018

Nov 09, 2018

BUY
$12.27 - $15.65 $8,331 - $10,626
679 Added 13.1%
5,862 $82,000
Q4 2017

Jan 31, 2018

BUY
$15.77 - $20.72 $36,428 - $47,863
2,310 Added 80.4%
5,183 $94,000
Q3 2017

Nov 08, 2017

BUY
$12.3 - $19.3 $35,337 - $55,448
2,873
2,873 $55,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.18B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.